The report provides a detailed analysis essential for establishing a Flurazepam production plant. It encompasses all critical aspects necessary for Flurazepam production, including the cost of Flurazepam production, Flurazepam plant cost, Flurazepam production costs, and the overall Flurazepam production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Flurazepam production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Flurazepam is a benzodiazepine sedative–hypnotic used for treating insomnia. It is widely used as a prescription medicine mainly used to help people who struggle with long-lasting sleep problems. It is taken to reduce trouble falling asleep and to decrease repeated waking during the night. It is also used in certain pre-procedure settings to reduce anxiety and help patients stay relaxed. It also finds its application in the preparation of combination therapies where controlled sedation is needed under medical supervision.
The market for Flurazepam is predominantly driven by its application as a sleeping aid for people who struggle with long-term insomnia, which significantly promotes its demand in the medical sector. Its application as a prescription medicine for long-term sleep problems greatly fuels its demand across the medical and pharmaceutical industries. Its role in helping patients who struggle with frequent night waking, early-morning awakening, or anxiety-related sleep issues supports its continued use in clinics and hospitals.
Growing attention toward sleep health, rising cases of chronic insomnia, and the need for dependable sedative medicines further strengthen its market growth. Several factors also influence industrial Flurazepam procurement, including the cost and availability of raw materials for formulation, strict drug-safety regulations, and the need to maintain consistent quality throughout production. Smooth logistics, reliable suppliers, advances in drug production, and adherence to environmental and packaging guidelines also impact its global market.
Raw Material for Flurazepam Production
According to the Flurazepam production plant project report, the major raw materials for Flurazepam production include 5-(2-fluorophenyl)-7-chloro-2,3-dihydro-1H-1,4-benzodiazepinone and Sodium Methoxide and Diethylamino-ethyl Chloride.
Production Process of Flurazepam
The extensive Flurazepam production cost report consists of the following industrial production processes:
- Production from 5-(2-fluorophenyl)-7-chloro-2,3-dihydro-1H-1,4-benzodiazepinone: The production process of Flurazepam begins with dissolving the starting benzodiazepinone intermediate, 5-(2-fluorophenyl)-7-chloro-2,3-dihydro-1H-1,4benzodiazepinone in a suitable solvent and treating it with sodium methoxide to activate the molecule for substitution. Once the mixture is cooled, a freshly prepared solution of diethylamino-ethyl chloride is introduced, which allows the new side chain to attach to the benzodiazepine core. Then, the reaction is left to proceed for an extended period to ensure complete conversion. Afterwards, the mixture is concentrated and worked up by dissolving the residue in an organic solvent, followed by washing to remove inorganic salts and leftover reagents. The organic layer is filtered and evaporated, leaving an oily intermediate that is then converted into its hydrochloride salt by exposing it to hydrogen chloride in ether. Finally, the resulting solid is collected and purified by recrystallisation, which results in the formation of Flurazepam as the final product.
Flurazepam is a compound that belongs to the class of benzodiazepines, specifically those used as hypnotics for sleep disorders. It is an odourless, pale yellow to white crystalline powder that is poorly soluble in water but more soluble in organic solvents such as ethanol. The molecular formula of Flurazepam is C21H23ClFN3O and its molar mass is approximately 387.88 g/mol. The density of the compound is estimated at around 1.21 g/cm³.
The melting point of the compound is about 77 – 82 degree Celsius, at which it also starts decomposing. The compound is non-volatile and degrades on heating. It is used as a sedative-hypnotic agent. It is recommended to handle the raw material using protective gloves and eye protection, as exposure to benzodiazepine powders poses risks of accidental ingestion or inhalation. Its prolonged use or high-dose exposure may lead to central nervous system depression and dependency.
